Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson’s disease

Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson’s disease

Parkinson’s disease is the most common movement disorder worldwide, affecting over 6 million people. It is an age-related disease, occurring in 1% of people over the age of 60, and 3% of the population over 80 years. The disease is characterized by the progressive loss of midbrain dopaminergic neuro...

Full description

Bibliographic Details
Main Authors: Susan R Goulding, Jayanth Anantha, Louise M Collins, Aideen M Sullivan, Gerard W O'Keeffe
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Neural Regeneration Research
Subjects:
adeno-associated virus; bone morphogenetic protein; dopaminergic neurons; growth/differentiation factor 5; neurodegeneration; neuroprotection; neurotrophic factor; parkinson’s disease; smad signaling; α-synuclein
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2022;volume=17;issue=1;spage=38;epage=44;aulast=Goulding

Internet

http://www.nrronline.org/article.asp?issn=1673-5374;year=2022;volume=17;issue=1;spage=38;epage=44;aulast=Goulding

Similar Items